Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Stock
Equities
301246
CNE100005ZB9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.94 CNY | +2.05% | +10.06% | -30.95% |
Sales 2022 | 2.06B 286M | Sales 2023 | 2.05B 284M | Capitalization | 10.39B 1.44B |
---|---|---|---|---|---|
Net income 2022 | 435M 60.21M | Net income 2023 | 87M 12.04M | EV / Sales 2022 * | - |
Net cash position 2022 | 51.05M 7.07M | Net cash position 2023 | 1.83B 253M | EV / Sales 2023 | 4.17 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
116
x | Employees | 2,075 |
Yield 2022 * |
-
| Yield 2023 |
0.19% | Free-Float | 37.32% |
1 day | +2.05% | ||
1 week | +10.06% | ||
Current month | +10.06% | ||
1 month | +0.96% | ||
3 months | -12.36% | ||
6 months | -35.88% | ||
Current year | -30.95% |
Managers | Title | Age | Since |
---|---|---|---|
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Ke Feng Zeng
DFI | Director of Finance/CFO | 39 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shou Ying Du
BRD | Director/Board Member | 64 | - |
Zhi Hua Deng
BRD | Director/Board Member | 54 | - |
Guo Ping Yin
FOU | Founder | 64 | 02-01-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 17.94 | +2.05% | 25,233,370 |
24-05-09 | 17.58 | +2.75% | 17,360,230 |
24-05-08 | 17.11 | +2.33% | 12,261,910 |
24-05-07 | 16.72 | +0.24% | 5,520,625 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-30.95% | 993M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 301246 Stock